ASTH — Astrana Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual cashflow statement for Astrana Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	49.3	50.5	57.8	49.9	24.1
Depreciation
Deferred Taxes
Non-Cash Items	29.6	31.3	28.5	42.2	52.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-20.1	-9.58	-23.4	-63.6	-3.1
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	70.3	82.1	68.2	52.2	115
Capital Expenditures	-19.2	-22.9	-28.5	-8.03	-10.1
Purchase of Fixed Assets
Other Investing Cash Flow Items	35.8	15.8	-37	-184	-529
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	16.5	-7.11	-65.5	-192	-539
Financing Cash Flow Items	-2.15	-4.61	-5.01	-5.07	-31.4
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-47.7	-20.1	3.42	135	569
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	39.1	54.9	6.13	-5.05	145